“We can deliver; give us the benefit of the doubt” EFPIA chief speaks out as pharma’s reputation comes under fire again
The patient pathway
Will the new PPRS help NICE shift its focus away from single products towards the entire care pathway?
Chewing the fat on obesity The World Health Organization has called it a pandemic – so just how big a problem is obesity?
Everything you wanted to know about the PPRS but were afraid to ask If you’re still scratching your head over what the new drug pricing scheme means, PharmaTimes recently held a meeting to find out more
Healthcare gets personal Personal health budgets are being seen as the best way to kick-start the change needed to create a truly patient-centred NHS. But others are uneasy…
No chain, no gain Globalisation, regulation and changes in the product mix are reshaping the pharmaceutical supply chain
Would you rather…. With Leslie Galloway, EMIG chairman and advocate of the UK pharma industry